Cargando…

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

BACKGROUND: The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Alexandra D, Nikoghosyan, Anna V, Lossner, Karen, Herfarth, Klaus K, Debus, Jürgen, Münter, Marc W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407497/ https://www.ncbi.nlm.nih.gov/pubmed/22551422 http://dx.doi.org/10.1186/1471-2407-12-163

Ejemplares similares

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity
por: Lang, Kristin, et al.
Publicado: (2018)

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
por: Schmid, Maximilian P., et al.
Publicado: (2021)

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Carbon ion therapy for ameloblastic carcinoma
por: Jensen, Alexandra D, et al.
Publicado: (2011)

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series
por: Karam, Sana D., et al.
Publicado: (2014)

Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck
por: Jensen, A D, et al.
Publicado: (2019)

Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
por: König, Laila, et al.
Publicado: (2021)

Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT
por: Hartel, Carola, et al.
Publicado: (2018)

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment
por: Münter, MW, et al.
Publicado: (2006)

Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx
por: Hauswald, H., et al.
Publicado: (2018)

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
por: Zwicker, Felix, et al.
Publicado: (2011)

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety
por: Akbaba, Sati, et al.
Publicado: (2019)

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Elective Node Irradiation With Integrated Boost to the Prostate Using Helical IMRT–Clinical Outcome of the Prospective PLATIN-1 Trial
por: Koerber, Stefan Alexander, et al.
Publicado: (2019)

Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome
por: Jensen, Alexandra D, et al.
Publicado: (2015)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
por: Jensen, A. D., et al.
Publicado: (2016)

In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer
por: Zwicker, Felix, et al.
Publicado: (2015)

Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff
por: Held, Thomas, et al.
Publicado: (2019)

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
por: Roeder, Falk, et al.
Publicado: (2014)

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety
por: Akbaba, Sati, et al.
Publicado: (2018)

Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature
por: Sterzing, Florian, et al.
Publicado: (2009)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
por: Habl, Gregor, et al.
Publicado: (2010)

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
por: Rochet, Nathalie, et al.
Publicado: (2007)

Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial
por: Askoxylakis, Vasileios, et al.
Publicado: (2011)

Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes
por: Combs, Stephanie E, et al.
Publicado: (2006)

Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol
por: Uhl, Matthias, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sl2kvuf3ejlu8nam2scerselv7